Signing out of account, Standby...
Sweta Jaiswal, FRM
Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging update in the coronavirus vaccine.
Here we discuss certain ETF strategies to help investors gain from optimism surrounding the upbeat earnings season amid recovering U.S. economy from the pandemic-led slump.
The third-quarter earnings season has started with a bang, spreading optimism among investors.
In an effort to combat the coronavirus outbreak and accelerate the distribution process of extra doses in the United States, the FDA has approved the vaccine booster shots.
The U.S. housing sector scenario seems to improve with strength in housing demand amid persistent supply-chain constraints that can impact affordability.
Surging raw material prices, power shortages, a slowdown in the property sector and COVID-related constraints are likely to have impeded third-quarter economic growth.
The U.S. consumer sentiment takes a hit in early October from the rising concerns over surging coronavirus cases and inflationary levels.
Wall Street is expected to continue gaining on optimism surrounding new economic data and third-quarter earnings releases, which point to recovery from the pandemic-induced slowdown.
Dividend aristocrats are likely to perform well and are attractive investment options for an impressive finish to 2021.
Take a look at some ETF areas that can be considered good investment options amid the rising inflation concerns.
Here we highlight some Quality ETFs that can be promising bets amid the current market conditions.